A new drug for migraine headaches in Europe

Author: Ibrahim Baho

European health authorities, represented Thursday by the European Commission, approved the use of a new drug, the first in 20 years, to cure the migraine that strikes the head of one of the seven people in the world. The new name is Imofig, manufactured by the Swiss pharmaceutical company Novartis, and can be used by patients once a month with the aid of injectable injections.
European approval comes after more than two months of approval of the US Food and Drug Administration (FDA). According to the Daily Mail, the drug is expected to be available in the UK market within 6 weeks, and the cost of a single injection is estimated at $ 438.
The paper noted that Imofig will be tested on patients in NHS hospitals in Britain, and will determine its effectiveness next year after being evaluated by the National Institute of Health and Medicine. excellence of care, the executive body of the British Ministry of Health
Migraine or migraine is the third most prevalent disease in the world. Caused by tension, and the type of light affects the skin Scientists confirm that it affects women three times more than men because of hormonal imbalances. Research shows that every million people in the world has about 3,000 migraine a day.
The new property, developed by British scientists for 3 years, decades, on a drug called irinumab, which targets a protein in the brain called the calcitonin-related peptide receptor (PCR-R), scientists say that it circulates the blood vessels with nerve endings in the brain, for the transmission of pain signals badociated with migraines.
According to
if (f.fbq) returns; n = f.fbq = function () {
n.callMethod?
n.callMethod.apply (n, arguments): n.queue.push (arguments)
} if (! f._fbq) f._fbq = n;
n.push = n; n.loaded =! 0; n.version = 2.0 & # 39 ;; n.queue = []; t = b.createElement (e); t.async =! 0;
t.src = v; s = b.getElementsByTagName (e) [0]; s.parentNode.insertBefore (t, s)
} (window,
document, "script", https: //connect.facebook.net/en_US/fbevents.js');

fbq (& # 39;) & # 39; 516568965216217 & # 39;);
fbq (& # 39; track & # 39 ;, "PageView");
[ad_2]
Source link